CXCL12 and benign prostatic hyperplasia: We analysed the changes in TNF-α, CCL2, IL-6, CXCL12, CXCL8 and VEGF levels and we found a reduced expression in response to ALCAR treatment of PCa and BPH cell lines (Fig. 8).